{"schema_version":"secwatch.filing_event.v1","accession":"0001428336-23-000031","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2023-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.898217+00:00","generated_at":"2026-06-10T23:52:25.466910+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HealthEquity Q2 revenue $243.5M (+18% YoY), net income $10.6M vs loss, EPS $0.53 non-GAAP","bullets":["Revenue $243.5M, up 18% YoY from $206.1M; net income $10.6M vs net loss $10.7M in prior year.","Non-GAAP EPS $0.53, up from $0.33; Adjusted EBITDA $88.1M (+31%), margin 36% vs 33%.","HSAs 8.2M (+9% YoY); total HSA assets $23.2B (+13%); HSA cash + investments $23.2B.","FY2024 guidance: revenue $980-990M, non-GAAP EPS $1.97-2.06, Adj. EBITDA $338-348M.","Record HSA asset growth and 360bps adjusted EBITDA margin expansion YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001428336-23-000031","json":"https://secwatch.observer/filing/0001428336-23-000031.json","markdown":"https://secwatch.observer/filing/0001428336-23-000031.md","text":"https://secwatch.observer/filing/0001428336-23-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000031/0001428336-23-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000031/hqy-20230905.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:52:25.466910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fe8a6ee4974651e23897637cc8c48abe1d054130","claim":"HEALTHEQUITY, INC. reported the second quarter ended July 31, 2023 results: revenue $243.5 million, net income $10.6 million, EPS $0.12 per diluted share.","evidence_excerpt":"Reports Second Quarter Ended July 31, 2023 Financial Results Delivers Record HSA Asset Growth, Margin Expansion Highlights of the second quarter include: • Revenue of $243.5 million, an increase of 18% compared to $206.1 million in Q2 FY23. • Net income of $10.6 million, compared to net loss of $10.7 million in Q2 FY23, with non-GAAP net income of $45.6","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000031/0001428336-23-000031-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended July 31, 2023"},{"label":"Revenue","value":"$243.5 million"},{"label":"Net income","value":"$10.6 million"},{"label":"EPS","value":"$0.12 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}